Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 8-K Event Regulation FD disclosure
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. SC TO-I/A Deal Tender Offer Statement by Issuer
  8. SC TO-I/A Deal Tender Offer Statement by Issuer
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SC TO-I Deal Tender Offer Statement by Issuer
  15. 4 Insider Changes in Ownership
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 4 Insider Changes in Ownership
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. SC TO-C Deal Written Communication Relating to an Issuer
  20. 8-K Event Material agreement · Results of operations · Executive or director change · Regulation FD disclosure · Other events

Page 5 of 27 · 537 filings